Matthew H Daniels

Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-Met.

Wei Lu, Michael D Altman, Craig Rosenstein, 2013, Journal of medicinal chemistry.

Palladium-catalyzed cross-coupling of benzyl thioacetates and aryl halides.

Matthew H Daniels, Krista M Wager, 2011, Organic letters.

Sequential Regioselective C-H Functionalization of Thiophenes.

K. Tan, Matthew H Daniels, J. Armand, 2016, Organic letters.

The development of a Selectfluor®-mediated oxidative Mannich reaction

Matthew H Daniels, J. Hubbs, 2011 .

Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model.

Maolin Yu, John F. Reilly, M. Beconi, 2019, ACS medicinal chemistry letters.

Purine derivatives as potent gamma-secretase modulators.

C. Kenific, A. Szewczak, J. Crispino, 2010, Bioorganic & medicinal chemistry letters.

A translational kidney organoid system bolsters human relevance of clinical development candidate

M. Emani, J. Harmange, P. Mundel, 2019, bioRxiv.

Discovery and Optimization of Highly Selective Inhibitors of CDK5.

J. Harmange, Matthew H Daniels, Srinivasan P. Venkatachalan, 2022, Journal of medicinal chemistry.